TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

J&J wins U.S. approval for TB tablet

JNJ $70.10 +$0.62

at close on MONDAY

By Anna Edney C.2012 Bloomberg News
Monday, Dec. 31, 2012, 10:30 p.m.
 

Johnson & Johnson won regulatory approval for its tuberculosis tablet Sirturo, the first drug in 40 years that provides a new way to treat the contagious lung infection.

The Food and Drug Administration cleared Sirturo to be added to therapies for use by adults whose illness is resistant to multiple medicines, the New Brunswick, N.J.- based company said Monday.

While tuberculosis was once the leading cause of death in the nation, the drug-resistant version of the illness affected about 98 people last year, according to the Centers for Disease Control and Prevention.

 

 
 


Show commenting policy

Most-Read Business Headlines

  1. Hospitals, doctors in Pa. received $32M in 5 months from drug, medical device companies
  2. Google Pittsburgh instrumental in fight against hackers, co-directors say
  3. Retirement planning is about more than just money
  4. EPA says greenhouse gas releases from wells, pipelines decline
  5. Education spending helps to widen wealth gap
  6. Trib 30 index of Pittsburgh-area stocks falls in September
  7. LNG exports get federal approval from Dominion’s Cove Point terminal
  8. Shareholders cheer eBay’s decision to spin off PayPal
  9. ‘Tug of war’ takes effect on stocks as market logs 3rd monthly drop for 2014
  10. Western Pa. unemployment rate holds steady in August
  11. Study: Wellness programs don't save money, but employee health improves
Subscribe today! Click here for our subscription offers.